CN Stock MarketDetailed Quotes

002422 Sichuan Kelun Pharmaceutical

Watchlist
  • 30.43
  • -0.08-0.26%
Market Closed Dec 20 15:00 CST
48.73BMarket Cap16.44P/E (TTM)

Sichuan Kelun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
6.64%16.79B
9.52%11.83B
10.32%6.22B
12.69%21.45B
12.93%15.74B
18.35%10.8B
25.79%5.64B
10.19%19.04B
9.88%13.94B
10.84%9.12B
Operating revenue
6.64%16.79B
9.52%11.83B
10.32%6.22B
12.69%21.45B
12.93%15.74B
18.35%10.8B
25.79%5.64B
10.19%19.04B
9.88%13.94B
10.84%9.12B
Other operating revenue
----
-0.83%363.93M
----
69.01%739.64M
----
82.92%366.98M
----
28.25%437.62M
----
17.72%200.62M
Total operating cost
-0.41%13.41B
0.92%9.24B
2.42%4.77B
6.12%18.28B
8.85%13.47B
11.36%9.15B
9.94%4.65B
5.73%17.22B
3.30%12.37B
5.17%8.22B
Operating cost
7.61%7.97B
7.95%5.46B
7.68%2.75B
12.89%10.21B
15.99%7.41B
20.96%5.06B
21.52%2.55B
18.02%9.04B
13.99%6.39B
15.70%4.18B
Operating tax surcharges
-10.25%208.89M
-11.17%137.12M
0.25%63.76M
20.51%302.73M
27.62%232.75M
39.70%154.35M
18.08%63.6M
12.23%251.2M
12.68%182.37M
7.82%110.48M
Operating expense
-19.54%2.61B
-12.83%1.92B
-5.84%1.1B
-5.89%4.45B
-4.02%3.25B
-2.32%2.2B
-2.97%1.17B
-5.86%4.73B
-10.13%3.39B
-9.53%2.25B
Administration expense
38.62%979.69M
23.89%614.3M
18.75%336.05M
22.93%1.14B
-18.31%706.77M
-17.14%495.86M
-14.45%283M
-18.64%929.03M
-1.65%865.19M
1.56%598.46M
Financial expense
-73.51%54.5M
-83.52%27.34M
-82.43%16.83M
-51.28%233.76M
-41.05%205.77M
-30.80%165.87M
-24.75%95.81M
-5.10%479.83M
-7.66%349.09M
-4.67%239.7M
-Interest expense (Financial expense)
-57.56%123.59M
-61.06%89.51M
-61.94%47.64M
-23.92%361.54M
-14.79%291.2M
-2.95%229.86M
0.30%125.17M
-8.32%475.22M
-12.33%341.72M
-7.06%236.86M
-Interest Income (Financial expense)
26.29%-55.95M
15.04%-40.96M
-33.29%-22.31M
-134.19%-103.59M
-122.55%-75.91M
-107.46%-48.22M
-115.35%-16.74M
-51.50%-44.23M
-59.71%-34.11M
-76.74%-23.24M
Research and development
-4.89%1.58B
0.21%1.08B
2.27%502.82M
8.27%1.94B
38.30%1.67B
28.99%1.08B
17.89%491.66M
3.37%1.8B
1.27%1.2B
8.87%834.07M
Credit Impairment Loss
0.71%-76.79M
-88.14%-69.7M
-411.67%-46.37M
26.41%-45.98M
-80.31%-77.34M
12.40%-37.05M
-18.19%-9.06M
-40.54%-62.49M
-248.21%-42.89M
-327.32%-42.29M
Asset Impairment Loss
34.55%-30.5M
44.15%-26.05M
--0
-195.95%-130.55M
-65.77%-46.6M
-88.97%-46.63M
-400.64%-14.76M
12.52%-44.11M
4.49%-28.11M
16.15%-24.68M
Other net revenue
34.50%436.17M
37.68%320.31M
24.99%180.87M
25.54%477.58M
15.00%324.29M
22.65%232.65M
69.16%144.71M
14.27%380.41M
25.57%281.98M
86.90%189.68M
Fair value change income
15,787.77%13.68M
67.43%5.47M
99.02%2.94M
48.73%14.67M
-102.71%-87.18K
82.19%3.26M
-38.96%1.48M
104.27%9.86M
127.39%3.22M
1,433.00%1.79M
Invest income
7.97%288.27M
24.71%213.76M
25.29%111.84M
52.99%358.88M
55.18%266.98M
56.41%171.41M
74.91%89.26M
9.19%234.58M
27.39%172.05M
140.77%109.59M
-Including: Investment income associates
5.32%273.16M
19.85%208.63M
-50.67%112.56M
54.30%352.11M
65.32%259.35M
78.41%174.07M
500.32%228.19M
79.25%228.19M
21.27%156.88M
138.22%97.57M
Asset deal income
-53.87%879.45K
-16.23%1.37M
156.42%646.02K
-51.34%2.63M
-51.70%1.91M
-60.80%1.64M
-128.15%-1.15M
168.01%5.4M
130.39%3.95M
138.65%4.18M
Other revenue
34.12%240.64M
39.59%195.46M
41.66%111.82M
17.19%277.94M
3.26%179.43M
-0.76%140.02M
156.41%78.93M
9.76%237.18M
21.67%173.77M
32.81%141.09M
Operating profit
46.68%3.81B
54.86%2.91B
44.77%1.63B
66.46%3.65B
40.59%2.6B
71.44%1.88B
238.15%1.13B
66.32%2.2B
98.46%1.85B
110.94%1.1B
Add:Non operating Income
36.48%6.16M
42.54%3.05M
196.74%1.69M
59.93%11.86M
93.00%4.52M
66.06%2.14M
54.58%570.68K
123.45%7.41M
17.29%2.34M
1.15%1.29M
Less:Non operating expense
96.59%110.48M
87.39%49.93M
-25.88%9.35M
-36.44%85.57M
-43.52%56.2M
-22.83%26.64M
28.42%12.61M
-7.49%134.64M
226.13%99.51M
97.78%34.52M
Total profit
45.56%3.71B
54.38%2.87B
45.65%1.62B
73.14%3.58B
45.44%2.55B
74.49%1.86B
244.29%1.12B
75.60%2.07B
93.97%1.75B
111.12%1.06B
Less:Income tax cost
94.82%784.66M
134.70%649.29M
118.01%338.99M
156.75%933.79M
37.88%402.77M
52.63%276.65M
193.29%155.5M
17.51%363.7M
86.87%292.1M
212.64%181.26M
Net profit
36.30%2.92B
40.31%2.22B
33.93%1.29B
55.30%2.65B
46.96%2.14B
78.98%1.58B
254.27%960.07M
96.31%1.7B
95.45%1.46B
97.92%882.31M
Net profit from continuing operation
36.30%2.92B
40.31%2.22B
33.93%1.29B
55.30%2.65B
46.96%2.14B
78.98%1.58B
254.27%960.07M
96.31%1.7B
95.45%1.46B
97.92%882.31M
Less:Minority Profit
150.46%450.08M
136.92%415.67M
78.28%259.61M
17,379.60%190.53M
240.06%179.7M
1,132.50%175.44M
814.69%145.62M
99.53%-1.1M
151.71%52.84M
130.28%14.23M
Net profit of parent company owners
25.85%2.47B
28.24%1.8B
26.00%1.03B
44.03%2.46B
39.70%1.96B
61.71%1.4B
179.52%814.45M
54.67%1.71B
65.68%1.41B
76.15%868.08M
Earning per share
Basic earning per share
16.30%1.57
18.56%1.15
17.54%0.67
38.52%1.69
35.00%1.35
56.45%0.97
185.00%0.57
56.41%1.22
66.67%1
77.14%0.62
Diluted earning per share
23.62%1.57
26.37%1.15
26.42%0.67
38.26%1.59
33.68%1.27
51.67%0.91
165.00%0.53
47.44%1.15
58.33%0.95
71.43%0.6
Other composite income
-124.00%-17.62M
-76.68%20.3M
-100.35%-845.21K
-125.22%-60.84M
-72.62%73.41M
-24.74%87.05M
1,312.52%241.24M
406.74%241.24M
930.49%268.13M
424.95%115.67M
Other composite income of parent company owners
-119.67%-13.92M
-76.21%20.15M
-100.61%-1.45M
-125.51%-60.37M
-72.90%70.76M
-25.01%84.7M
1,321.41%236.68M
419.93%236.68M
914.57%261.15M
421.12%112.95M
Other composite income of minority owners
-239.56%-3.7M
-93.58%151.09K
-86.81%601.78K
-110.35%-472.44K
-62.03%2.65M
-13.45%2.35M
980.31%4.56M
197.77%4.56M
3,195.79%6.98M
744.00%2.72M
Total composite income
30.99%2.9B
34.20%2.24B
6.96%1.28B
32.91%2.59B
28.39%2.22B
66.96%1.67B
378.41%1.2B
146.43%1.95B
141.86%1.73B
143.29%997.98M
Total composite income of parent company owners
20.79%2.46B
22.29%1.82B
-2.51%1.02B
23.36%2.4B
22.05%2.03B
51.72%1.49B
286.45%1.05B
88.81%1.94B
104.18%1.67B
114.37%981.03M
Total composite income of minority owners
144.79%446.38M
133.87%415.82M
73.27%260.22M
5,391.29%190.05M
204.81%182.35M
948.81%177.8M
818.80%150.18M
101.45%3.46M
158.41%59.82M
135.73%16.95M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 6.64%16.79B9.52%11.83B10.32%6.22B12.69%21.45B12.93%15.74B18.35%10.8B25.79%5.64B10.19%19.04B9.88%13.94B10.84%9.12B
Operating revenue 6.64%16.79B9.52%11.83B10.32%6.22B12.69%21.45B12.93%15.74B18.35%10.8B25.79%5.64B10.19%19.04B9.88%13.94B10.84%9.12B
Other operating revenue -----0.83%363.93M----69.01%739.64M----82.92%366.98M----28.25%437.62M----17.72%200.62M
Total operating cost -0.41%13.41B0.92%9.24B2.42%4.77B6.12%18.28B8.85%13.47B11.36%9.15B9.94%4.65B5.73%17.22B3.30%12.37B5.17%8.22B
Operating cost 7.61%7.97B7.95%5.46B7.68%2.75B12.89%10.21B15.99%7.41B20.96%5.06B21.52%2.55B18.02%9.04B13.99%6.39B15.70%4.18B
Operating tax surcharges -10.25%208.89M-11.17%137.12M0.25%63.76M20.51%302.73M27.62%232.75M39.70%154.35M18.08%63.6M12.23%251.2M12.68%182.37M7.82%110.48M
Operating expense -19.54%2.61B-12.83%1.92B-5.84%1.1B-5.89%4.45B-4.02%3.25B-2.32%2.2B-2.97%1.17B-5.86%4.73B-10.13%3.39B-9.53%2.25B
Administration expense 38.62%979.69M23.89%614.3M18.75%336.05M22.93%1.14B-18.31%706.77M-17.14%495.86M-14.45%283M-18.64%929.03M-1.65%865.19M1.56%598.46M
Financial expense -73.51%54.5M-83.52%27.34M-82.43%16.83M-51.28%233.76M-41.05%205.77M-30.80%165.87M-24.75%95.81M-5.10%479.83M-7.66%349.09M-4.67%239.7M
-Interest expense (Financial expense) -57.56%123.59M-61.06%89.51M-61.94%47.64M-23.92%361.54M-14.79%291.2M-2.95%229.86M0.30%125.17M-8.32%475.22M-12.33%341.72M-7.06%236.86M
-Interest Income (Financial expense) 26.29%-55.95M15.04%-40.96M-33.29%-22.31M-134.19%-103.59M-122.55%-75.91M-107.46%-48.22M-115.35%-16.74M-51.50%-44.23M-59.71%-34.11M-76.74%-23.24M
Research and development -4.89%1.58B0.21%1.08B2.27%502.82M8.27%1.94B38.30%1.67B28.99%1.08B17.89%491.66M3.37%1.8B1.27%1.2B8.87%834.07M
Credit Impairment Loss 0.71%-76.79M-88.14%-69.7M-411.67%-46.37M26.41%-45.98M-80.31%-77.34M12.40%-37.05M-18.19%-9.06M-40.54%-62.49M-248.21%-42.89M-327.32%-42.29M
Asset Impairment Loss 34.55%-30.5M44.15%-26.05M--0-195.95%-130.55M-65.77%-46.6M-88.97%-46.63M-400.64%-14.76M12.52%-44.11M4.49%-28.11M16.15%-24.68M
Other net revenue 34.50%436.17M37.68%320.31M24.99%180.87M25.54%477.58M15.00%324.29M22.65%232.65M69.16%144.71M14.27%380.41M25.57%281.98M86.90%189.68M
Fair value change income 15,787.77%13.68M67.43%5.47M99.02%2.94M48.73%14.67M-102.71%-87.18K82.19%3.26M-38.96%1.48M104.27%9.86M127.39%3.22M1,433.00%1.79M
Invest income 7.97%288.27M24.71%213.76M25.29%111.84M52.99%358.88M55.18%266.98M56.41%171.41M74.91%89.26M9.19%234.58M27.39%172.05M140.77%109.59M
-Including: Investment income associates 5.32%273.16M19.85%208.63M-50.67%112.56M54.30%352.11M65.32%259.35M78.41%174.07M500.32%228.19M79.25%228.19M21.27%156.88M138.22%97.57M
Asset deal income -53.87%879.45K-16.23%1.37M156.42%646.02K-51.34%2.63M-51.70%1.91M-60.80%1.64M-128.15%-1.15M168.01%5.4M130.39%3.95M138.65%4.18M
Other revenue 34.12%240.64M39.59%195.46M41.66%111.82M17.19%277.94M3.26%179.43M-0.76%140.02M156.41%78.93M9.76%237.18M21.67%173.77M32.81%141.09M
Operating profit 46.68%3.81B54.86%2.91B44.77%1.63B66.46%3.65B40.59%2.6B71.44%1.88B238.15%1.13B66.32%2.2B98.46%1.85B110.94%1.1B
Add:Non operating Income 36.48%6.16M42.54%3.05M196.74%1.69M59.93%11.86M93.00%4.52M66.06%2.14M54.58%570.68K123.45%7.41M17.29%2.34M1.15%1.29M
Less:Non operating expense 96.59%110.48M87.39%49.93M-25.88%9.35M-36.44%85.57M-43.52%56.2M-22.83%26.64M28.42%12.61M-7.49%134.64M226.13%99.51M97.78%34.52M
Total profit 45.56%3.71B54.38%2.87B45.65%1.62B73.14%3.58B45.44%2.55B74.49%1.86B244.29%1.12B75.60%2.07B93.97%1.75B111.12%1.06B
Less:Income tax cost 94.82%784.66M134.70%649.29M118.01%338.99M156.75%933.79M37.88%402.77M52.63%276.65M193.29%155.5M17.51%363.7M86.87%292.1M212.64%181.26M
Net profit 36.30%2.92B40.31%2.22B33.93%1.29B55.30%2.65B46.96%2.14B78.98%1.58B254.27%960.07M96.31%1.7B95.45%1.46B97.92%882.31M
Net profit from continuing operation 36.30%2.92B40.31%2.22B33.93%1.29B55.30%2.65B46.96%2.14B78.98%1.58B254.27%960.07M96.31%1.7B95.45%1.46B97.92%882.31M
Less:Minority Profit 150.46%450.08M136.92%415.67M78.28%259.61M17,379.60%190.53M240.06%179.7M1,132.50%175.44M814.69%145.62M99.53%-1.1M151.71%52.84M130.28%14.23M
Net profit of parent company owners 25.85%2.47B28.24%1.8B26.00%1.03B44.03%2.46B39.70%1.96B61.71%1.4B179.52%814.45M54.67%1.71B65.68%1.41B76.15%868.08M
Earning per share
Basic earning per share 16.30%1.5718.56%1.1517.54%0.6738.52%1.6935.00%1.3556.45%0.97185.00%0.5756.41%1.2266.67%177.14%0.62
Diluted earning per share 23.62%1.5726.37%1.1526.42%0.6738.26%1.5933.68%1.2751.67%0.91165.00%0.5347.44%1.1558.33%0.9571.43%0.6
Other composite income -124.00%-17.62M-76.68%20.3M-100.35%-845.21K-125.22%-60.84M-72.62%73.41M-24.74%87.05M1,312.52%241.24M406.74%241.24M930.49%268.13M424.95%115.67M
Other composite income of parent company owners -119.67%-13.92M-76.21%20.15M-100.61%-1.45M-125.51%-60.37M-72.90%70.76M-25.01%84.7M1,321.41%236.68M419.93%236.68M914.57%261.15M421.12%112.95M
Other composite income of minority owners -239.56%-3.7M-93.58%151.09K-86.81%601.78K-110.35%-472.44K-62.03%2.65M-13.45%2.35M980.31%4.56M197.77%4.56M3,195.79%6.98M744.00%2.72M
Total composite income 30.99%2.9B34.20%2.24B6.96%1.28B32.91%2.59B28.39%2.22B66.96%1.67B378.41%1.2B146.43%1.95B141.86%1.73B143.29%997.98M
Total composite income of parent company owners 20.79%2.46B22.29%1.82B-2.51%1.02B23.36%2.4B22.05%2.03B51.72%1.49B286.45%1.05B88.81%1.94B104.18%1.67B114.37%981.03M
Total composite income of minority owners 144.79%446.38M133.87%415.82M73.27%260.22M5,391.29%190.05M204.81%182.35M948.81%177.8M818.80%150.18M101.45%3.46M158.41%59.82M135.73%16.95M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday+1.17%
Bird Flu
Bird Flu
Intraday+0.81%
Virus Prevention
Virus Prevention
Intraday+0.60%